HAVCR2 and breast cancer: Furthermore, Burugu et al. recently investigated the immunohistochemical expression of TIM-3 in 3992 breast cancer specimens in tissue microarray along with other biomarkers, including CD8, PD-1, PD-L1, and LAG-3 [37].